T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Titan Machinery
TITN
$420M
| $284K | ﹤0.01% |
+10,033
| New | +$284K |
|
2402
NWPX Infrastructure Inc
NWPX
$1.11B
| $283K | ﹤0.01% |
+10,038
| New | +$307K |
|
2403
ACV Auctions
ACVA
$1.35B
| $279K | ﹤0.01% |
38,685
+8,625
| +29% | +$68.5K |
|
|
XOMA
2404
DELISTED
Xoma
XOMA
| $279K | ﹤0.01% |
15,534
+2,200
| +16% | +$45.3K |
|
2405
Canterbury Park Holding Corp
CPHC
$81.4M
| $278K | ﹤0.01% |
12,479
| – | – |
|
2406
HealthStream
HSTM
$849M
| $278K | ﹤0.01% |
13,062
+1,379
| +12% | +$31.4K |
|
|
PZN
2407
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $278K | ﹤0.01% |
29,383
+11,659
| +66% | +$102K |
|
2408
Butterfly Network
BFLY
$2.36B
| $276K | ﹤0.01% |
58,653
-241
| -0.4% | -$1.27K |
|
|
TPIC
2409
DELISTED
TPI Composites
TPIC
| $276K | ﹤0.01% |
24,402
-28,350
| -54% | -$448K |
|
2410
Oil States International
OIS
$526M
| $274K | ﹤0.01% |
70,198
+39,157
| +126% | +$187K |
|
2411
RCI Hospitality Holdings
RICK
$230M
| $273K | ﹤0.01% |
+4,172
| New | +$260K |
|
|
HSKA
2412
DELISTED
Heska Corp
HSKA
| $273K | ﹤0.01% |
3,739
+608
| +19% | +$53.7K |
|
|
FIRY
2413
Firy Inc
FIRY
$158M
| $272K | ﹤0.01% |
13,300
+6,992
| +111% | +$197K |
|
2414
Arcturus Therapeutics
ARCT
$223M
| $271K | ﹤0.01% |
18,247
+1,515
| +9% | +$25.4K |
|
2415
Cytek Biosciences
CTKB
$636M
| $271K | ﹤0.01% |
18,403
+7,508
| +69% | +$97.5K |
|
2416
Inogen
INGN
$154M
| $271K | ﹤0.01% |
11,138
+1,364
| +14% | +$37.7K |
|
|
MAGN
2417
Magnera Corp
MAGN
$433M
| $271K | ﹤0.01% |
6,686
+4,801
| +255% | +$334K |
|
2418
Evolus
EOLS
$530M
| $270K | ﹤0.01% |
33,534
+7,823
| +30% | +$82.9K |
|
2419
CarParts.com
PRTS
$50.3M
| $270K | ﹤0.01% |
5,212
+1,112
| +27% | +$80.8K |
|
2420
Vanguard Morningstar Total Stock Market ETF
VTI
$696B
| $270K | ﹤0.01% |
1,500
| – | – |
|
|
CVGW
2421
DELISTED
Calavo Growers
CVGW
| $268K | ﹤0.01% |
8,437
-2,125
| -20% | -$85.3K |
|
2422
Kura Sushi USA
KRUS
$646M
| $267K | ﹤0.01% |
+3,620
| New | +$279K |
|
2423
CRA International
CRAI
$1.07B
| $265K | ﹤0.01% |
2,979
-552
| -16% | -$50.7K |
|
2424
Personalis
PSNL
$1.54B
| $265K | ﹤0.01% |
88,900
+26,300
| +42% | +$100K |
|
2425
Microvast
MVST
$341M
| $263K | ﹤0.01% |
145,108
+59,638
| +70% | +$143K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.